- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
May 25th, 2005
Jack Uldrich: Last week, privately-held Dendritic NanoTechnologies Inc. (DNT) announced that it had developed a new family of scalable, precision dendrimer nanostructures. The technology is called Priostar ™ and it could radically change the economics of nanotechnology.
The news is not only important for the emerging nanotech industry, it is especially good news for Dow Chemical (NYSE: DOW) and Starpharma (Nasdaq: SPHRY) -- both of whom own 30% of DNT apiece.
|Related News Press|
'Material universe' yields surprising new particle November 28th, 2015
New 'self-healing' gel makes electronics more flexible November 25th, 2015
Nanometrics Announces Upcoming Investor Events November 18th, 2015
Nanoparticles simplify DNA identification and quantification November 27th, 2015
Scientists 'see' detailed make-up of deadly toxin for the first time: Exciting advance provides hope for developing novel potential method of treating pneumococcal diseases such as bacterial pneumonia, meningitis and septicaemia November 25th, 2015